7094
T. L. Schull et al. / Tetrahedron 56 (2000) 7093–7097
from sodium/benzophenone; hexane, hexanes and CH2Cl2,
distilled from CaH2; ethyl acetate, methanol, acetone, acetic
acid (Fisher), ethanol (Aaper Alcohol and Chemical Co.),
anhydrous DME (Aldrich), CDCl3, acetone-d6 and D2O
(Cambridge Isotope Laboratories), used as received. Silica
gel (Scientific Products, 230–400 mesh), magnesium sulfate
and sodium sulfate (Fisher) were used as received.
over a period of 20–30 min. The ice-bath was removed and
the mixture stirred overnight at room temperature. The reac-
tion mixture was cooled to 0ЊC (ice-bath) and water was
carefully added (375 mL). The reaction mixture was then
poured into ether (500 mL) and the two phases separated.
The aqueous phase was washed with ether (200 mL) and the
organic fractions combined and dried over anhydrous
Na2SO4. Then, the ether solution was concentrated using
rotary evaporation to give a yellow oil which solidified on
standing. The residue was taken up in hexane and chroma-
tographed on a 50 mm diameter column (179 g silica gel,
ether–hexane). The solvent was removed from the eluate to
give 2 as spectroscopically pure colorless oil (22.01 g,
77%). IR (NaCl, thin film): n(O–H) 3321 cmϪ1, n(C–O)
Reagents were obtained as follows: cyclohexene, 1-hexene,
1-decene, 2,4,6-collidine, sodium dodecyl sulfate, trityl
chloride, sodium hydroxide (Aldrich), hydrogen (MG
Industries), 10% palladium–charcoal (MC&B), sodium
borohydride, tetraethylammonium perchlorate (Fluka),
TiCl4, perchloric acid, hydriodic acid, triethylamine
(Fisher), LiPPh2, prepared according to Ref. 21; p-toluene-
sulfonyl chloride (Aldrich), recrystallized before use;
di-n-butylphosphosphite (Aldrich), vacuum distilled prior
to use; m-CPBA was purified according to the literature
procedure.7 [Rh(COD)2]BF4 was synthesized according to
the literature procedure.8
1
1051 cmϪ1. H NMR (CDCl3): d 3.64 (t, 2H, HOCH2–),
3.19 (2H, t, ICH2), 1.82 (m, 2H, HOCH2CH2–), 1.63–1.23
(m, 20H, CH2).
12-Iodododecan-1-ol trityl ether (3). A 250 mL Schlenk
flask was equipped with magnetic stirrer bar and charged
with 2 (15.61 g, 50.00 mmol), trityl chloride (13.94 g,
50.00 mmol), and Et4NClO4 (11.49 g, 50.00 mmol) and
CH2Cl2 (200 mL). Then, 1.5 equiv. of 2,4,6-collidine
(9.9 mL, 7.5 mol) was added via syringe and the solution
was stirred for ca. 30 min. Water (200 mL) was added and
the two phases were separated. The organic phase was
washed with water and dried over anhydrous MgSO4.
Then, the solution was concentrated using rotary evapora-
tion and the resulting oil chromatographed on a 50 mm
diameter column (201 g silica gel, ether–hexane). The
solvent was removed from the eluate to give 3 as an orange
oil (24.30 g, 90%). 1H NMR (CDCl3): d 7.54–7.16 (m, 15H,
3C6H5), 3.17 (2H, t, ICH2), 3.03 (2H, t, CH2OC–), 1.80 (m,
2H, ICH2CH2–), 1.61 (m, 2H, C–OCH2CH2–), 1.44–1.06
(m, 18H, CH2).
12-Iodododecan-1-oic acid (1). A 500 mL flask was
charged with cyclododecanone (27.35 g, 0.1500 mol),
m-CPBA (43.97 g, 0.255 mol) and CH2Cl2 (200 mL).
Then, trifluoroacetic acid (0.12 mL, 1.5 mmol) was added
and the mixture was refluxed for 45 h. The reaction was
allowed to cool to room temperature and the resulting
white solid was filtered off. The filtrate was diluted with
CH2Cl2 (800 mL), washed successively with K2CO3 solu-
tion (2×250 mL), water (250 mL) and sodium thiosulfate
solution (250 mL). The organic phase was dried over
anhydrous MgSO4 and the solvent removed via rotary
evaporation. The residue was dissolved in 95% EtOH
(100 mL) and NaBH4 (0.378 g, 0.010 mmol) in EtOH
(10 mL) was added and the reaction mixture was stirred
for 30 min. Then, 1 M hydrochloric acid solution
(100 mL) and ether (200 mL) were added. Solvent was
removed from the organic phase via rotary evaporation and
the resulting residue was transferred to a 500 mL round-
bottom flask equipped with a reflux condensor and stirrer
bar. Hydriodic acid (100 mL, 0.76 mol, 57%) was added via
syringe and immediately followed by acetic acid (100 mL).
The solution was refluxed for 3 h during which time the color
changed from orange to pale yellow. The solution was
allowed to cool to room temperature and separated into two
phases. The mixture was poured onto water (1000 mL) and a
precipitate immediately formed, which was collected by filtra-
tion, air-dried and then dried under oil-pump vacuum. Crystal-
lization from hexanes (300 mL) gave 1 as pink flakes
(30.85 g, 63%), mp 69–71ЊC. IR (KBr disk): n(CvO)
12-Di-n-butylphosphonododecan-1-ol trityl ether (4). A
500 mL Schlenk flask was equipped with a mechanical
stirrer, pressure-equalizing addition funnel, reflux con-
denser and charged with sodium metal (1.27 g,
55.0 mmol) and hexane (125 mL). The mixture was heated
to reflux and a solution of di-n-butylphosphite (10.7 mL,
55.0 mmol) in hexane (25 mL) was added dropwise with
stirring. The mixture was refluxed overnight and then
allowed to cool to room temperature. A solution of 3
(21.45 g, 39.50 mmol) in hexane (50 mL) was added drop-
wise. The mixture was refluxed overnight, allowed to cool
to room temperature and quenched with 10% NaCl solution
(100 mL). Ether (100 mL) was added and the two phases
separated. The organic phase was washed with a portion of
10% NaCl solution (100 mL) and the aqueous phase
extracted with ether (100 mL). The ether fractions were
combined, dried (anhydrous Na2SO4) and solvent removed
on a rotary evaporator. The resulting residue was chromato-
graphed on a 50 mm diameter column (150 g silica gel,
ethyl acetate). The solvent was removed from the eluate
to give 4 as a pale yellow oil (22.64 g, 92%). IR (NaCl,
1
1691 cmϪ1. H NMR (CDCl3): d 3.19 (t, 2H, ICH2–), 2.35
(t, 2H, HO2CCH2–), 1.82 (m, 2H, HO2CH2CH2–), 1.63 (m,
2H, ICH2CH2–), 1.45–1.25 (m, 14H, CH2). MS (EI-MS): m/e
199 (100%) (M Ϫ127).
12-Iodododecan-1-ol (2). A 1 L three-neck, round-bottom
flask was equipped with a mechanical stirrer, septum and a
pressure-equalized dropping funnel. The flask was charged
with sodium borohydride (11.45 g, 0.3030 mol) and
anhydrous DME (350 mL). The flask was then cooled in
an ice bath and TiCl4 (11.1 mL, 0.101 mol) was added via
syringe. Then, a solution of 1 (30.00 g, 92.00 mmol) in
anhydrous DME (150 mL) was added via a dropping funnel
1
thin film): n(PO3) 1071, 1026, 1003, 978 cmϪ1. H NMR
(CDCl3): d 7.30–7.50 (m, 15H, 3C6H5), 4.05 (m, 4H,
2CH2OP) 3.05, (2H, t, CH2OC–), 1.80–1.20 (m, 22H,
CH2), 0.93 (t, 6H, 2CH3). 31P NMR (CDCl3): d 33.3 (s).
12-Di-n-butylphosphonododecan-1-ol (5). A 1 L Parr